サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1334211

核酸標識の世界市場

Nucleic Acid Labeling
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 179 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
核酸標識の世界市場
出版日: 2023年08月22日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 179 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

核酸標識の世界市場は2030年までに43億米ドルに達する

COVID-19後のビジネス環境が変化する中、2022年に24億米ドルと推計された核酸標識の世界市場は、2030年までに43億米ドルに達すると予測され、2022年から2030年にかけてCAGR 7.5%で成長すると予測されます。本レポートで分析されているセグメントの一つである試薬は、CAGR8.3%を記録し、分析期間終了時には22億米ドルに達すると予測されています。現在進行中のパンデミック後の回復を考慮し、キット分野の成長は今後8年間のCAGRを7.2％に修正しました。

米国市場は7億2,960万米ドル、中国はCAGR6.9％で成長すると予測

米国の核酸標識市場は、2022年に7億2,960万米ドルと推定されます。世界第2位の経済大国である中国は、2022年から2030年までの分析期間においてCAGR 6.9%で推移し、2030年までに7億3,710万米ドルの市場規模に達すると予測されています。その他の注目すべき地理的市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ7.2%と6%の成長が予測されています。欧州では、ドイツがCAGR約6%で成長すると予測されています。

調査対象企業の例

  • Agilent Technologies, Inc.
  • Enzo Biochem, Inc.
  • F. Hoffmann-La Roche AG
  • General Electric Company
  • Merck KgaA
  • New England Biolabs, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • Thermo Fisher Scientific, Inc.
  • Vector Laboratories, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP13640

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Nucleic Acid Labeling Market to Reach $4.3 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Nucleic Acid Labeling estimated at US$2.4 Billion in the year 2022, is projected to reach a revised size of US$4.3 Billion by 2030, growing at aCAGR of 7.5% over the period 2022-2030. Reagents, one of the segments analyzed in the report, is projected to record 8.3% CAGR and reach US$2.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Kits segment is readjusted to a revised 7.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $729.6 Million, While China is Forecast to Grow at 6.9% CAGR

The Nucleic Acid Labeling market in the U.S. is estimated at US$729.6 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$737.1 Million by the year 2030 trailing a CAGR of 6.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.2% and 6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6% CAGR.

Select Competitors (Total 12 Featured) -

  • Agilent Technologies, Inc.
  • Enzo Biochem, Inc.
  • F. Hoffmann-La Roche AG
  • General Electric Company
  • Merck KgaA
  • New England Biolabs, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • Thermo Fisher Scientific, Inc.
  • Vector Laboratories, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Nucleic Acid Labeling - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World 8-Year Perspective for Nucleic Acid Labeling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for DNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 4: World 8-Year Perspective for DNA Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Fluorescence in Situ Hybridization (FISH) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 6: World 8-Year Perspective for Fluorescence in Situ Hybridization (FISH) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World 8-Year Perspective for Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Blotting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 10: World 8-Year Perspective for Blotting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for in Situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 12: World 8-Year Perspective for in Situ Hybridization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World 8-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Nick Translation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 16: World 8-Year Perspective for Nick Translation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Random Primer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 18: World 8-Year Perspective for Random Primer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for In Vitro Transcription by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 20: World 8-Year Perspective for In Vitro Transcription by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 21: World Recent Past, Current & Future Analysis for Reverse Transcription by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 22: World 8-Year Perspective for Reverse Transcription by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 23: World Nucleic Acid Labeling Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 25: World 8-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 27: World 8-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 29: World 8-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Other Labeling Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 31: World 8-Year Perspective for Other Labeling Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction (PCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 33: World 8-Year Perspective for Polymerase Chain Reaction (PCR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 34: USA Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 35: USA 8-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2023 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 37: USA 8-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2023 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: USA 8-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2023 & 2030
  • CANADA
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 41: Canada 8-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2023 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 43: Canada 8-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2023 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Canada 8-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2023 & 2030
  • JAPAN
    • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 47: Japan 8-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2023 & 2030
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 49: Japan 8-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2023 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Japan 8-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2023 & 2030
  • CHINA
    • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 52: China Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 53: China 8-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2023 & 2030
    • TABLE 54: China Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 55: China 8-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2023 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: China 8-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2023 & 2030
  • EUROPE
    • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 58: Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 59: Europe 8-Year Perspective for Nucleic Acid Labeling by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 60: Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 61: Europe 8-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2023 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Europe 8-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2023 & 2030
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 65: Europe 8-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2023 & 2030
  • FRANCE
    • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 66: France Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 67: France 8-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2023 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: France 8-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2023 & 2030
    • TABLE 70: France Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 71: France 8-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2023 & 2030
  • GERMANY
    • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 72: Germany Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 73: Germany 8-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2023 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Germany 8-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2023 & 2030
    • TABLE 76: Germany Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 77: Germany 8-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2023 & 2030
  • ITALY
    • TABLE 78: Italy Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 79: Italy 8-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2023 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Italy 8-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2023 & 2030
    • TABLE 82: Italy Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 83: Italy 8-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2023 & 2030
  • UNITED KINGDOM
    • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 84: UK Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 85: UK 8-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2023 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: UK 8-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2023 & 2030
    • TABLE 88: UK Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 89: UK 8-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 90: Rest of Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 91: Rest of Europe 8-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2023 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Rest of Europe 8-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2023 & 2030
    • TABLE 94: Rest of Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 95: Rest of Europe 8-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2023 & 2030
  • ASIA-PACIFIC
    • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 96: Asia-Pacific Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 97: Asia-Pacific 8-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2023 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific 8-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2023 & 2030
    • TABLE 100: Asia-Pacific Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 101: Asia-Pacific 8-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2023 & 2030
  • REST OF WORLD
    • TABLE 102: Rest of World Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 103: Rest of World 8-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2023 & 2030
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Rest of World 8-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2023 & 2030
    • TABLE 106: Rest of World Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 107: Rest of World 8-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2023 & 2030

IV. COMPETITION